Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate. 1987

J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
Department of Obstetrics and Gynecology, University of Alabama Medical Center, Birmingham.

Fifteen patients with nonmetastatic gestational trophoblastic disease were treated solely with methotrexate given orally rather than intramuscularly. Remission, defined as a beta-human chorionic gonadotropin titer of less than 5 mIU/ml for 3 consecutive weeks, was attained in 13 (87%) of the 15 patients. Level of toxicity was acceptable. Patient comfort, convenience, and less time off work and in the physician's office are significant advantages to this efficacious, well-tolerated method of therapy.

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014328 Trophoblastic Neoplasms Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed, p1691) Trophoblastic Cancer,Trophoblastic Tumor,Neoplasms, Trophoblastic,Trophoblast Cancer,Trophoblast Neoplasms,Trophoblast Tumor,Cancer, Trophoblast,Cancer, Trophoblastic,Cancers, Trophoblast,Cancers, Trophoblastic,Neoplasm, Trophoblast,Neoplasm, Trophoblastic,Neoplasms, Trophoblast,Trophoblast Cancers,Trophoblast Neoplasm,Trophoblast Tumors,Trophoblastic Cancers,Trophoblastic Neoplasm,Trophoblastic Tumors,Tumor, Trophoblast,Tumor, Trophoblastic,Tumors, Trophoblast,Tumors, Trophoblastic
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
September 1988, Obstetrics and gynecology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
September 1982, American journal of obstetrics and gynecology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
July 1989, Journal of surgical oncology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
January 1993, European journal of gynaecological oncology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
September 1988, Obstetrics and gynecology clinics of North America,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
April 1995, Seminars in oncology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
September 1976, Obstetrics and gynecology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
December 1979, Obstetrics and gynecology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
February 1996, Gynecologic oncology,
J F Barter, and S J Soong, and K D Hatch, and J W Orr, and E C Partridge, and J M Austin, and H M Shingleton
February 1995, American journal of obstetrics and gynecology,
Copied contents to your clipboard!